Dobri Kiprov, MD, HP is internationally recognized as a pioneer and a leading expert in the field of Therapeutic Apheresis and longevity. Dr. Kiprov is the former Chief of the Division of lmmunotherapy at California Pacific Medical Center in San Francisco, California and the current Medical Director and President of Global Apheresis, Inc. He has worked in the field of therapeutic apheresis for more than 30 years and has published extensively on this subject. Dr. Kiprov served two terms on the American Society for Apheresis (ASFA) Board of Directors and is currently a member of the Boad of Directors of the International Society for Apheresis (ISFA). He serves as an Associate Editor of several apheresis and longevity journals. Dr. Kiprov's extensive experience with immune system disorders has led to the development of therapeutic programs that foster immune system health and longevity through his unique approach. He is co-founder of LYFSPN, a company involved in the development of longevity therapies. Dr. Kiprov is the recipient of multiple awards in recognition of his contribution to the field of apheresis and immunology and he is the first physician to be Board Certified in Hemapheresis. Dr. Kiprov is currently involved in several immunology clinical trials.